Hematology Frontier

Editor’s Note: In the golden season of autumn, leading experts gathered in the City of the Future to discuss the frontiers of cell therapy. On October 31, 2025, the 2025…

Editor’s Note: As autumn brings its golden harvest, scientific progress likewise flourishes. The 2025 Chinese Research Hospital Association Conference on Cell Therapy and Biomedical Frontiers, jointly organized by the Cell…

Editor’s Note: Universal CAR-T cell therapy has emerged as one of the most dynamic frontiers in cellular immunotherapy. Characterized by its “off-the-shelf” availability and broad clinical potential, it has drawn…

Editor’s Note: With the rapid development of medical technology, modern lymphoma treatment has become a key focus in the field of oncology. From May 25 to 26, the Modern Lymphoma…

On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology and Rare Disease Foundation, and hosted by the Beijing Lu Daopei Hematology Institute. The conference gathered world-leading hematology experts and focused on hematopoietic stem cell transplantation, cellular therapy, and precision treatment of hematologic malignancies. With over a thousand participants, the meeting provided a high-level and in-depth academic exchange. During the conference, Professor Fang Liu from Shanghai Xindaobei Hematology Hospital delivered a presentation on the latest clinical advances of CAR-T therapy in acute myeloid leukemia (AML). Oncology Frontier – Hematology News invited Professor Liu to elaborate on the core clinical issues, offering important insights to guide optimized management strategies.

On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology and Rare Disease…

On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology and Rare Disease…

On August 22–23, 2025, the 13th Ludaopei Hematology Conference was grandly held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology and Rare Disease…

Editor’s Note: As autumn scents the air with osmanthus blossoms, leading scientists gathered in Kumamoto for an intellectual feast. The 54th Annual Scientific Meeting of the International Society for Experimental…

The European Society for Medical Oncology (ESMO) Congress 2025 was grandly held in Berlin, marking another wave of scientific innovation across the field of oncology.In hematology, several exciting advances drew attention—from uncovering the mechanisms of CAR-T resistance and exploring dual-target immunotherapies, to studies on precision treatment discontinuation in multiple myeloma and single-cell immune atlas mapping that deepens our understanding of hematologic malignancies. Together, these studies highlight continuous innovation in medical science and bring new hope for improving diagnosis and treatment in hematologic diseases.To further focus on major breakthroughs in hematology and foster academic exchange, Oncology Frontier – Hematology News invited Dr. Sicong Zhang, from Professor Huilai Zhang’s research group at Tianjin Medical University Cancer Institute and Hospital, to discuss the innovation and clinical significance of a new study presented at ESMO 2025, as well as to share his insights into future trends in the field.